Nephrocare Health Services IPO
Nephrocare Health Services IPO Details
-
Open Date
10 Dec 2025
-
Close Date
12 Dec 2025
-
Listing Date
17 Dec 2025
- IPO Price Range
₹ 438 to ₹460
- IPO Size
₹ 871.05 Cr
- Listing Exchange
BSE NSE
Nephrocare Health Services IPO Timeline
Last Updated: 05 December 2025 4:58 PM by 5paisa
Nephrocare Health Limited, launching a ₹871. 05 Cr IPO, delivers comprehensive dialysis care through 519 clinics across India and select international markets, including the Philippines, Uzbekistan, and Nepal, hosting the world’s largest dialysis centre in Uzbekistan. Offering diagnosis, haemodialysis, home and mobile dialysis, wellness programmes, and an in-house pharmacy, the company primarily serves tier II and III cities. In FY2025, it treated over 29,000 patients with 2.88 million dialysis sessions and partners with leading hospital chains for in-house centres.
Established in: 2010
Managing Director: Vikram Vuppala
Peers:
| Metric | Nephrocare Health Limited | Narayana Health | Jupiter Life Line Hospitals | Rainbow Children Hospital | Dr. Agarwal’s Healthcare | Dr. Lal Path Labs |
|
Face Value (₹ per share) |
2.00 | 10.00 | 10.00 |
10.00 |
1 | 10.00 |
| Face Value (₹ per share) | NA | 1758.80 | 1506.00 | 1355.10 | 498.80 | 3064.10 |
| P/E | [•] | 45.21 | 51.10 | 56.84 | 179.42 | 52.84 |
| Revenue from Operations (₹ Cr) | 755.81 | 5482.98 | 1261.55 | 1515.87 | 1711.00 | 2461.40 |
|
Earnings Per Share (Basic) (₹) |
8.28 | 38.90 | 29.47 | 23.97 | 2.80 | 58.48 |
| Earnings Per Share (Diluted) (₹) | 8.01 | 38.90 | 29.47 | 23.84 | 2.78 | 58.40 |
| Return on Net Worth (RoNW) (%) | 13.19 | 21.77 | 14.27 | 16.56 | 5.73 | 22.30 |
| NAV per equity share (₹) |
59.56 | 160.35 | 192.55 | 134.69 | 55.13 | 245.26 |
Nephrocare Health Services Objectives
1. The company plans ₹129.11 crore for new dialysis clinics in India.
2. The company intends ₹136.00 crore for repayment of borrowings.
3. The company will utilise funds for general corporate purposes.
Nephrocare Health IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹871.05 Cr |
| Offer For Sale | ₹517.64 Cr |
| Fresh Issue | ₹353.40 Cr |
Nephrocare Health IPO Lot Size
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 32 | 14,016 |
| Retail (Max) | 13 | 416 | 1,91,3609 |
| S-HNI (Min) | 14 | 448 | 1,96,224 |
| S-HNI (MAX) | 67 | 2,144 | 9,86,240 |
| B-HNI (Min) | 68 | 2,176 | 9,53,088 |
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Revenue | 437.30 | 566.16 | 755.81 |
| EBITDA | 48.60 | 99.66 | 166.64 |
| PAT | 98.14 | 286.20 | 81.87 |
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Total Assets | 666.23 | 806.02 | 996.46 |
| Share Capital | 1.74 | 1.75 | 1.77 |
| Total Liabilities | 277.60 | 392.31 | 412.35 |
| Cash Flows (₹ Crores) | FY23 | FY24 | FY25 |
| Net Cash Generated From / (used in) Operating Activities | 11.27 | 72.28 | 135.35 |
| Net Cash Generated From / (used in) Investing Activities | -78.21 | -50.66 | -125.07 |
| Net Cash Generated From / (used in) Financing Activities | 59.97 | 26.74 | 54.37 |
| Net Increase (Decrease) in Cash and Cash Equivalents | -6.97 | 48.36 | 64.65 |
Strengths
1. The company operates 519 clinics across multiple countries.
2. Strong presence in underserved tier II and III cities.
3. Strategic partnerships with leading hospital chains nationwide.
4. Offers comprehensive services including home and mobile dialysis.
Weaknesses
1. Heavy dependence on dialysis services for revenue generation.
2. Limited presence in metro cities compared to smaller towns.
3. High capital expenditure required for clinic expansion.
4. Reliance on in-house pharmacy may constrain flexibility.
Opportunities
1. Expansion potential in international markets like Nepal and Uzbekistan.
2. Growing demand for dialysis due to rising kidney diseases.
3. Opportunities for wellness and preventive care programmes.
4. Technological advancements can enhance treatment efficiency and reach.
Threats
1. Intense competition from other dialysis service providers.
2. Regulatory changes could affect operational and financial performance.
3. Economic downturns may reduce patients’ ability to pay.
4. Supply chain disruptions could impact dialysis machine availability.
1. The company holds significant market share in dialysis services.
2. Strong growth potential across underserved tier II, III cities.
3. Strategic partnerships with leading hospitals enhance credibility nationwide.
4. Comprehensive services offer long-term revenue and expansion opportunities.
Nephrocare Health Services Ltd. operates a vast dialysis network across India and select international markets, primarily targeting tier II and III cities. With over 519 clinics and 5,562 dialysis machines, it addresses a significant healthcare gap. The rising prevalence of kidney diseases and growing demand for home, mobile, and in-clinic dialysis services positions the company for robust growth and increasing market share in the coming years.
- Companies
- Type
- Opening On
-
Wakefit Innovations
- Mainboard
- 08th Dec
- Pre-Book
-
Corona Remedies
- Mainboard
- 08th Dec
- Pre-Book
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Nephrocare Health IPO opens from December 10, 2025 to December 12, 2025.
The size of Nephrocare Health IPO is ₹871.05.
The price band of Nephrocare Health IPO is fixed at ₹438 to ₹460 per share.
To apply for Nephrocare Health IPO, follow the steps given below:
● Login to your 5paisa demat account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Nephrocare Health. IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Nephrocare Health IPO is of 32 shares and the investment required is ₹14,016.
The share allotment date of Nephrocare Health IPO is December 15, 2025
The Nephrocare Health IPO will likely be listed on December 17, 2025.
ICICI Securities Ltd is the book running lead managers for Nephrocare Health IPO.
Nephrocare Health IPO plans to utilise the raised capital from the IPO for:
1. The company plans ₹129.11 crore for new dialysis clinics in India.
2. The company intends ₹136.00 crore for repayment of borrowings.
3. The company will utilise funds for general corporate purposes.